ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2540

Effect of Buccal Hygiene on the Systemic Activity of Patients with Rheumatoid Arthritis: A Randomized Clinical Trial

Xavier Mariette1, Elodie Perrodeau2, Christian Verner3, Xavier Struillou4, Thierry Schaeverbeke5, Alain Cantagrel6, Philippe Ravaud7 and Philippe Bouchard8, 1Rheumatology, Université Paris Sud, Le Kremlin Bicêtre, France, 2Paris Hotel Dieu, Paris, France, 3Periodontology, UFR d'odontologie, University of Nantes, Nantes, France, 4Periodontology, UFR d'odontologie, University of Nantes,, Nantes, France, 5Rheumatology, CHU Bordeaux, Bordeaux, France, 6Rheumatology, CHU Toulouse, Toulouse, France, 7INSERM UMR1153, Paris Descartes University, Paris, France, 8Paris Diderot University, Paris, France

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: Periodontitis, rheumatoid arthritis (RA) and treatment

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Rheumatoid Arthritis – Treatments Poster III: Biosimilars and New Compounds

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Good evidence suggests a relationship between rheumatoid arthritis (RA) and periodontitis. We aimed to investigate if a good oral hygiene could improve activity of RA.

Methods:

BHYRRA (Buccal HYgiene and Reduction of activity of RA) is a randomized trial nested in the French early arthritis ESPOIR cohort. The patients with RA according to ACR/EULAR 2010 criteria and included in the ESPOIR cohort were randomized into 2 groups:

  • Group A: treated according to a periodontal care program of good oral hygiene proposed to the general population, which included: (1) tooth brushing twice a day with a Triclosan polymer dentifrice (Colgate Total®); (2) mouth rinse once a day with an antiseptic mouthwash including essential oils (Listerin®); (3) scaling by a periodontist twice a year.
  • Group B: no specific intervention and no specific information was given to the patients.

In both groups the treatment of RA was conducted according to the decision of the physician.

The primary endpoint was the delta between M12 and M0 DAS28-VS in both groups. The ability of the intervention to decrease the gingiva bacterial load was also analyzed.

Given the fact that it was expected that numbers of patients in whom the intervention will be proposed will not accept it, the primary analysis was a complier average causal effect (CACE) analysis, restricted to patients having their first visit to the dentist planned in group A. Two approaches were used for CACE analyses; 1) weighting and 2) instrumental variable (IV).

PCR analysis of nine periodontal pathogens was performed at M0 and M12.

Results:

472 patients from the ESPOIR cohort were randomized, 238 in the intervention group (A) and 234 in the control group (B). 92/238 from group A accepted the procedure but only 81/92 had a first visit to the dentist. Duration of RA was 9.7 +/- 1.1 years. Baseline DAS28-VS was 2.65 +/- 1.31 and 2.72 +/- 1.26 in group A and B, respectively. Delta DAS was -0.19 +/- 1.37 and -0.02 +/- 1.18 in group A and B respectively (weighted difference: -0.02 (95%CI -0.38 ; 0.33), p =0.90; IV: -0.37 (CI 95% -1.12 ; 0.37) p = 0.33). In anti-CCP positive patients, the delta DAS28-VS was -0.20 +/- 1.51 and 0.03 +/- 1.26 in group A and B respectively (weighted difference: -0.03 (95%CI -0.55 ; 0.49), p =0.92; IV: -0.43 (CI 95% -1.37 ; 0.51), p = 0.37). For the patients becoming negative to the red complex, there was a decrease of DAS albeit not significant (-0.30 (95%CI -1.12 ; 0.51), p=0.47)

Microbiological analysis of the periodontal bacteria indicated a significant decrease in the red complex involved in the pathogenesis of periodontitis; i.e. Porphyromonas gingivalis (p = 0.002), Tannerella forsythia (p = 0.002) and Treponema denticola (p = 0.019).

Conclusion:

Following in RA patients the recommendations to the general population for a good oral hygiene decreased the bacterial load of bacteria involved in periodontal disease but did not improve RA activity. In the present study, the lack of clinical effect on RA may be due (1) to the relatively long duration of the disease in the patients enrolled (10 years), and (2) to the very good control of the disease at baseline (DAS28-VS around 2.7). The efficacy of oral prevention, through the above simple approach should be tested in patients with earlier RA and more active disease.


Disclosure: X. Mariette, None; E. Perrodeau, None; C. Verner, None; X. Struillou, None; T. Schaeverbeke, Pfizer, Inc., 2, 5,UCB, Inc., 5,Amgen Inc., 5,AbbVie Inc., 5,Janssen, 5,Roche, 5,BMS, 5,MSD, 5,Novartis, 5; A. Cantagrel, None; P. Ravaud, None; P. Bouchard, None.

To cite this abstract in AMA style:

Mariette X, Perrodeau E, Verner C, Struillou X, Schaeverbeke T, Cantagrel A, Ravaud P, Bouchard P. Effect of Buccal Hygiene on the Systemic Activity of Patients with Rheumatoid Arthritis: A Randomized Clinical Trial [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/effect-of-buccal-hygiene-on-the-systemic-activity-of-patients-with-rheumatoid-arthritis-a-randomized-clinical-trial/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-buccal-hygiene-on-the-systemic-activity-of-patients-with-rheumatoid-arthritis-a-randomized-clinical-trial/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology